Severe obesity complicates ICU drug dosing, review concludes
A narrative review concludes that severe obesity can complicate ICU drug dosing and supports individualized regimens based on pharmacokinetic variability ...
A narrative review concludes that severe obesity can complicate ICU drug dosing and supports individualized regimens based on pharmacokinetic variability ...
A targeted narrative review proposes a systems-pharmacology framework for designing antibiotic combinations around drug exposure, bacterial state and location within ...
A retrospective single-center analysis of 760 blood cultures from patients with sepsis found positive growth in 25.8% of samples and ...
A new review argues that conventional EC50 and EC90 values are context-dependent dynamic phenotypes shaped by viral kinetics, host-cell biology, ...
A validated translational platform linking lesion drug penetration to Phase 3 trial outcomes offers a new way to design shorter ...
A new computational study of Pseudomonas aeruginosa shows that transient population dynamics and inoculum size fundamentally reshape antibiotic susceptibility, prompting ...
A first-in-human phase 1a trial in China found that single intramuscular doses of the PEGylated recombinant uricase HZBio1 were well ...
A clinical trial finds that the traditional Korean formulations Bojungikgitang and Cheongsanggyeontongtang substantially raise or lower edoxaban exposure in healthy ...
A translational modelling study finds that PD-1 receptor occupancy does not predict immune activation during pembrolizumab therapy, challenging current dosing ...
Researchers are using PD-L1-targeted PET/CT imaging to directly visualise whether the immunotherapy drug atezolizumab saturates its target in tumours, offering ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine